SCHEMBL3637140

SCHEMBL3637140

COC(=O)C(Br)c1cccc(C)n1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 3/20 0.42
HTT P42858 1/20 0.41
RECQL P46063 1/20 0.41
P2RX7 Q99572 1/20 0.40
KMT2A Q03164 5/20 0.38
MEN1 O00255 4/20 0.38
GBA1 P04062 2/20 0.38
IRAK4 Q9NWZ3 1/20 0.38
NPC1 O15118 1/20 0.38
MAPT P10636 1/20 0.38
TSHR P16473 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
GRM5 P41594 4/20 0.38
OPRM1 P35372 1/20 0.38
OPRD1 P41143 1/20 0.38
FDPS P14324 1/20 0.37
FDFT1 P37268 1/20 0.37
POLB P06746 1/20 0.37
ALDH1A1 P00352 1/20 0.37
HPGD P15428 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3509941 0.83 IRAK4 (0.41) RAB9ARECQLKMT2AIRAK4NPC1
SCHEMBL17827993 0.81 RAB9A (0.43) RAB9AHTTRECQLP2RX7KMT2A
SCHEMBL16545968 0.81 RAB9A (0.43) RAB9AHTTRECQLP2RX7KMT2A
SCHEMBL18595268 0.80 RAB9A (0.42) RAB9AHTTRECQLP2RX7KMT2A
SCHEMBL31724126 0.76 SMN1; SMN2 (0.49) RAB9AHTTRECQLP2RX7KMT2A
SCHEMBL75590 0.75 KMT2A (0.47) RAB9AKMT2AMEN1NPC1MAPT
SCHEMBL27964846 0.72 KMT2A (0.41) RAB9AHTTKMT2AMEN1NPC1
SCHEMBL3750331 0.71 CYP1A2 (0.47) RAB9AHTTRECQLP2RX7KMT2A
SCHEMBL13044617 0.71 MEN1 (0.43) HTTRECQLKMT2AMEN1IRAK4
SCHEMBL10180444 0.71 P2RX7 (0.41) RAB9AHTTRECQLP2RX7KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100286152-A1 N-PHENYL HYDRAZIDES AS MODULATORS OF THE GHRELIN RECEPTOR GLAXO GROUP LIMITED (GB) 2010-11-11 US disclosed
US-20100286152-A1 N-PHENYL HYDRAZIDES AS MODULATORS OF THE GHRELIN RECEPTOR GLAXO GROUP LIMITED (GB) 2010-11-11 US disclosed
US-20100286152-A1 N-PHENYL HYDRAZIDES AS MODULATORS OF THE GHRELIN RECEPTOR GLAXO GROUP LIMITED (GB) 2010-11-11 US disclosed
EP-2167466-A1 N-PHENYL HYDRAZIDES AS MODULATORS OF THE GHRELIN RECEPTOR Glaxo Group Limited (GB) 2010-03-31 EP disclosed
WO-2008148853-A1 N-PHENYL HYDRAZIDES AS MODULATORS OF THE GHRELIN RECEPTOR GLAXO GROUP LIMITED (GB) 2008-12-11 WO disclosed
WO-2008148853-A1 N-PHENYL HYDRAZIDES AS MODULATORS OF THE GHRELIN RECEPTOR GLAXO GROUP LIMITED (GB) 2008-12-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100286152-A1 N-PHENYL HYDRAZIDES AS MODULATORS OF THE GHRELIN RECEPTOR GIPR, GHSR, GLP1R RAB9A 1127/4885HTT 316/4885RECQL 4756/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.